SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
SEC Accession No. 0001104659-16-120125
Filing Date
2016-05-11
Accepted
2016-05-11 17:27:42
Documents
1
Period of Report
2016-03-31
Effectiveness Date
2016-05-11

Document Format Files

Seq Description Document Type Size
1 NT 10-Q a16-11074_1nt10q.htm NT 10-Q 62602
  Complete submission text file 0001104659-16-120125.txt   63765
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Filer) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: NT 10-Q | Act: 34 | File No.: 001-34921 | Film No.: 161640907
SIC: 2834 Pharmaceutical Preparations